FHTX
NASDAQ · Biotechnology
Foghorn Therapeutics Inc
$4.61
+0.08 (+1.77%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+528.9% upside
Low Target
$18.54
Average Target
$28.99
High Target
$38.99
Current Price
$4.61
Current
$4.61
$4.61
Target
$28.99
$28.99
$18.54
$28.99 avg
$38.99
Scenario Analysis
Bear Case
$18.54
302.2%
Low target
Base Case
$28.99
+528.9%
Avg target
Bull Case
$38.99
+745.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$6.95
-33.7% from high
52-Week Low
$3.27
+41.0% from low
Target vs 52W High
$28.99
+317.1% vs high
Next Earnings Report
Aug 11, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.26
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |